Mahesh Krishnan - Net Worth and Insider Trading
Mahesh Krishnan Net Worth
The estimated net worth of Mahesh Krishnan is at least $51,497 dollars as of 2025-06-28. Mahesh Krishnan is the Director of Chinook Therapeutics Inc and owns about 1,275 shares of Chinook Therapeutics Inc (KDNY) stock worth over $51,497. Details can be seen in Mahesh Krishnan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mahesh Krishnan has not made any transactions after 2023-04-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mahesh Krishnan
Mahesh Krishnan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mahesh Krishnan owns 1 companies in total, including Chinook Therapeutics Inc (KDNY) .
Click here to see the complete history of Mahesh Krishnan’s form 4 insider trades.
Insider Ownership Summary of Mahesh Krishnan
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
KDNY | Chinook Therapeutics Inc | 2023-04-04 | director |
Mahesh Krishnan Latest Holdings Summary
Mahesh Krishnan currently owns a total of 1 stock. Mahesh Krishnan owns 1,275 shares of Chinook Therapeutics Inc (KDNY) as of April 4, 2023, with a value of $51,497.
Latest Holdings of Mahesh Krishnan
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KDNY | Chinook Therapeutics Inc | 2023-04-04 | 1,275 | 40.39 | 51,497 |
Holding Weightings of Mahesh Krishnan
Mahesh Krishnan Form 4 Trading Tracker
According to the SEC Form 4 filings, Mahesh Krishnan has made a total of 1 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Chinook Therapeutics Inc is the sale of 924 shares on April 4, 2023, which brought Mahesh Krishnan around $21,261.
Insider Trading History of Mahesh Krishnan
- 1
Mahesh Krishnan Trading Performance
Mahesh Krishnan Ownership Network
Ownership Network List of Mahesh Krishnan
Ownership Network Relation of Mahesh Krishnan

Mahesh Krishnan Owned Company Details
What does Chinook Therapeutics Inc do?
Who are the key executives at Chinook Therapeutics Inc?
Mahesh Krishnan is the director of Chinook Therapeutics Inc. Other key executives at Chinook Therapeutics Inc include Head of Renal Discovery Andrew James King , director & President & CEO Eric Dobmeier , and director & 10 percent owner Davis Jerel .
Chinook Therapeutics Inc (KDNY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Chinook Therapeutics Inc (KDNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chinook Therapeutics Inc (KDNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Chinook Therapeutics Inc (KDNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chinook Therapeutics Inc Insider Transactions
Mahesh Krishnan Mailing Address
Above is the net worth, insider trading, and ownership report for Mahesh Krishnan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mahesh Krishnan's mailing address is: Philadelphia Pa 19104.